Abiopharma

Murphy Patrick Michael 🟡 adjusted position in 6.5K shares of iRhythm Holdings, Inc. (IRTC) at $124.65 Transaction Date: Aug 07, 2026 | Filing ID: 000009

Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Patterson Chad 🟡 adjusted position in 6.5K shares of iRhythm Holdings, Inc. (IRTC) at $124.65 Transaction Date: Aug 07, 2026 | Filing ID: 000012

(30% Negative) AN2 THERAPEUTICS, INC. (ANTX) Reports Q3 2026 Financial Results

Pridgen Robert 🔴 sold 8.0K shares of INTERFACE INC (TILE) at $38.30 Transaction Date: Aug 11, 2026 | Filing ID: 000005

(10% Negative) FEDERAL REALTY INVESTMENT TRUST (FRT) Files Form 8-K

📋 Walker John D. III (Officer) plans to sell 5K shares of CENTRAL GARDEN & PET CO (at $38.50 each, total $192K) Filed: Aug 11, 2026 | ID: 000826

Shrishrimal Sumi 🟡 adjusted position in 4.3K shares of iRhythm Holdings, Inc. (IRTC) at $124.65 Transaction Date: Aug 07, 2026 | Filing ID: 000010

Press Release: AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

(30% Negative) FOLD HOLDINGS, INC. (FLDDW) Reports Q3 2026 Financial Results

(99% Neutral) ONFOLIO HOLDINGS, INC (ONFOW) Announces Regulatory Update

Mirum Pharma - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

(10% Negative) SMART SAND, INC. (SND) Reports Q3 2026 Financial Results